Search research articles
Contact Us
Filters
Showing results (1-10 of 207) with videos related to
Page
of 21
Sort By:
The Lancet. Oncology
|
November 6, 2010
FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?
Richard Kim
The Lancet. Oncology
|
October 31, 2009
Cetuximab and panitumumab: are they interchangeable?
Richard Kim
Cancer Treatment Reviews
|
January 17, 2009
Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions
Carryn Anderson, Richard Kim
Clinical Colorectal Cancer
|
December 16, 2011
To give or not to give anti-epidermal growth factor receptor (EGFR) monoclonal antibodies to patients with KRAS G13D mutation in advanced colorectal cancer
Richard Kim, Timothy Kubal
Journal of Gastrointestinal Cancer
|
August 18, 2010
Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation
Richard Kim, Federico Aucejo
Oncology (Williston Park, N.Y.)
|
October 22, 2008
Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard?
Khaldoun Almhanna, Richard Kim
JAMA Oncology
|
September 2, 2016
Treatment of Gastric and Gastroesophageal Cancers-Do We Really Need Anthracyclines?
Noman Ashraf, Richard Kim
Expert Opinion on Pharmacotherapy
|
October 25, 2007
Role of platinum agents in the management of advanced pancreatic cancer
Muhammad Wasif Saif, Richard Kim
JOP : Journal of the Pancreas
|
May 15, 2007
Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?
Richard Kim, Muhammad Wasif Saif
AJR. American Journal of Roentgenology
|
March 22, 2002
Clinical importance of a unilateral striated pattern seen on sonography of the testicle
David D Casalino, Richard Kim
Page
of 21
Search research articles
Search
Showing results (1-10 of 207) with videos related to
Sort By:
Page
of 21
The Lancet. Oncology
|
November 6, 2010
FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?
Richard Kim
The Lancet. Oncology
|
October 31, 2009
Cetuximab and panitumumab: are they interchangeable?
Richard Kim
Cancer Treatment Reviews
|
January 17, 2009
Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions
Carryn Anderson, Richard Kim
Clinical Colorectal Cancer
|
December 16, 2011
To give or not to give anti-epidermal growth factor receptor (EGFR) monoclonal antibodies to patients with KRAS G13D mutation in advanced colorectal cancer
Richard Kim, Timothy Kubal
Journal of Gastrointestinal Cancer
|
August 18, 2010
Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation
Richard Kim, Federico Aucejo
Oncology (Williston Park, N.Y.)
|
October 22, 2008
Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard?
Khaldoun Almhanna, Richard Kim
JAMA Oncology
|
September 2, 2016
Treatment of Gastric and Gastroesophageal Cancers-Do We Really Need Anthracyclines?
Noman Ashraf, Richard Kim
Expert Opinion on Pharmacotherapy
|
October 25, 2007
Role of platinum agents in the management of advanced pancreatic cancer
Muhammad Wasif Saif, Richard Kim
JOP : Journal of the Pancreas
|
May 15, 2007
Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?
Richard Kim, Muhammad Wasif Saif
AJR. American Journal of Roentgenology
|
March 22, 2002
Clinical importance of a unilateral striated pattern seen on sonography of the testicle
David D Casalino, Richard Kim
Page
of 21